Fluoropyrimidine-based adjuvant chemotherapy , including fluorouracil and leucovorin , has been widely used ; however , the addition of oxaliplatin to fluorouracil and leucovorin ( FOLFOX ) , a standard adjuvant regimen for colon cancer , has not been tested in rectal cancer .